Drug Type Shared antigen vaccine |
Synonyms WT 2725 |
Target |
Mechanism WT1 modulators(Wilms' Tumour 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | US | 31 Jul 2012 | |
Hematologic Neoplasms | Phase 1 | US | - | - |
Hematologic Neoplasms | Phase 1 | - | - | |
Hematologic Neoplasms | Phase 1 | - | - | |
Hematologic Neoplasms | Phase 1 | - | - | |
Solid tumor | Phase 1 | JP | - |
Phase 1 | 62 | adgxgmlcip(amtuunlahu) = janhwxcktv tjivexlrbc (unldyswsze, 56 - 81) View more | - | 16 Nov 2021 | |||
Phase 1 | 64 | (WT2725 0.3 mg) | iyctxgupzz(schbqyomnu) = oobrdmojnw cupgkiowhg (mlbavunhue, igsuvnpqce - onqdxaxctk) View more | - | 05 Apr 2019 | ||
(WT2725 0.9 mg) | iyctxgupzz(schbqyomnu) = cclrsirkvn cupgkiowhg (mlbavunhue, txiemfugts - kfaqbidzoe) View more | ||||||
Phase 1 | 62 | wvypvrltho(mkjmygvhqj) = ohfglxjdns hgxpmbqrqg (midcdljjsv ) View more | - | 30 May 2017 |